Key Takeaways:
- Sprout AI Inc. and TheraCann International Benchmark Corp. have initiated a controlled wind-down of active operations while working to preserve core assets and intellectual property.
- The move follows the repeated non-completion of previously announced financing transactions, leaving the Company unable to sustain operations at prior levels.
- The planned Amalgamation on the Canadian Securities Exchange to create Beyond Farming International Ltd. remains incomplete.
- The Company currently has no Chief Financial Officer, no audit engagement in place, and does not expect to file audited annual financial statements by its May 28, 2026 deadline.
- Management is exploring strategic alternatives including asset sales, partnerships, and recapitalization, but has offered no assurances that any pathway will be successfully completed.
A Difficult but Deliberate Step Back
Sprout AI Inc. and its parent company TheraCann International Benchmark Corp. have confirmed they are winding down active operations in a controlled manner after a series of financing transactions failed to close. The capital shortfall left the Company without the resources needed to maintain its prior level of activity, pushing management toward a structured pullback rather than an unmanaged collapse.
Operations have been scaled back or suspended across multiple jurisdictions. International initiatives and deployment plans that were previously in progress have been set aside for now, with funding limitations cited as the primary reason.
The Deal That Did Not Come Together
CSE Amalgamation Remains Incomplete
Central to the Company's original growth trajectory was a planned Amalgamation on the Canadian Securities Exchange, which would have combined its entities into a new company called Beyond Farming International Ltd. That process has stalled. No revised timeline has been offered, and its completion remains contingent on factors the Company has not yet resolved.
